Stay updated on EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial
Sign up to get notified when there's something new on the EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial page.

Latest updates to the EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial page
- Check2 days agoChange DetectedUpdated the study locations by adding new sites across multiple countries (Georgia, Ciudad Autónoma de BuenosAires, Córdoba Province, Antwerpen, Brussels Capital, Federal District, Rio Grande do Sul, São Paulo, Ontario, Hong Kong, Alpes-Maritimes, Maine-et-Loire, Nord, Lombardy, Piedmont, The Marches, Veneto, Silesian Voivodeship, Gauteng, Balearic Islands, Barcelona, Caceres, Murcia, İzmir, Tekirdağ, and more). Removed several previously listed location blocks.SummaryDifference2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2 updated on the page; this is an internal version update and does not affect study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page no longer displays the general government funding operating status notice; core study details such as title, sponsor, locations, and eligibility criteria remain unchanged.SummaryDifference0.2%

- Check52 days agoChange DetectedCore study details, locations, eligibility criteria, and outcomes remain unchanged between versions; observed differences appear to be minor formatting adjustments in the presentation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about funding-related operating status; removed the previous v3.1.0 tag.SummaryDifference4%

- Check88 days agoChange DetectedCore content sections on drug safety and related topics were removed, and a new version tag v3.1.0 was added. This indicates content consolidation and a version upgrade with less emphasis on the previously listed drug-safety topics.SummaryDifference0.4%

Stay in the know with updates to EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial page.